Victor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.
University of Cambridge Molecular Immunity Unit, MRC Laboratory of Molecular Biology, Cambridge, UK.
Science. 2024 Jul 5;385(6704):eadi0908. doi: 10.1126/science.adi0908.
The major human bacterial pathogen causes multidrug-resistant infections in people with underlying immunodeficiencies or structural lung diseases such as cystic fibrosis (CF). We show that a few environmental isolates, driven by horizontal gene acquisition, have become dominant epidemic clones that have sequentially emerged and spread through global transmission networks over the past 200 years. These clones demonstrate varying intrinsic propensities for infecting CF or non-CF individuals (linked to specific transcriptional changes enabling survival within macrophages); have undergone multiple rounds of convergent, host-specific adaptation; and have eventually lost their ability to transmit between different patient groups. Our findings thus explain the pathogenic evolution of and highlight the importance of global surveillance and cross-infection prevention in averting the emergence of future epidemic clones.
主要的人类细菌病原体 可导致存在潜在免疫缺陷或结构性肺部疾病(如囊性纤维化 (CF))的人群发生多种药物耐药感染。我们表明,少数环境分离株通过水平基因获得已成为优势流行克隆,这些克隆在过去 200 年中通过全球传播网络相继出现并传播。这些克隆显示出不同的内在倾向,即感染 CF 或非 CF 个体(与使巨噬细胞内存活的特定转录变化相关);经历了多轮趋同的、宿主特异性的适应性进化;最终丧失了在不同患者群体之间传播的能力。因此,我们的研究结果解释了 的致病进化,并强调了全球监测和交叉感染预防在避免未来流行克隆出现方面的重要性。